Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone - Trial NCT06321666
Access comprehensive clinical trial information for NCT06321666 through Pure Global AI's free database. This phase not specified trial is sponsored by European Institute of Oncology and is currently Recruitment Completed. The study focuses on Metastatic Breast Cancer. Target enrollment is 58 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
European Institute of Oncology
Timeline & Enrollment
N/A
Sep 12, 2019
Dec 31, 2024
Primary Outcome
Proportion of disease progression in bone metastasis identified by WB-MRI prior to CT scan
Summary
This is a non randomized, single arm study, where each patient will undergo imaging with
 Computed Tomography (CT) and Whole-body magnetic resonance imaging (WB-MRI) at different
 timepoint. The primary endpoint is time to progression as documented by CT or WB-MRI.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06321666
Non-Device Trial